JPMorgan analyst Andrea Teixeira raised the firm’s price target on Colgate-Palmolive to $91 from $90 and keeps an Overweight rating on the shares post the Q4 report. The quality of the earnings growth ahead of Colgate in 2024 will be even better, with more balanced volume versus pricing due to the company’s multi-year reinvestment in marketing, the analyst tells investors in a research note. As such, the firm remains confident the stock can continue to work.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CL:
- Colgate-Palmolive (NYSE:CL) Gains on Strong Q4 Print
- Options Volatility and Implied Earnings Moves Today, January 26, 2024
- Colgate-Palmolive reports Q4 base gross profit margin up 400 bps to 59.6%
- Colgate-Palmolive ‘well positioned’ to deliver compounded EPS growth in FY24
- Colgate-Palmolive sees FY24 net revenue growth 1%-4%, consensus $20.07B
